Product Images Gabapentin

This text contains medical formulas used for evaluating certain parameters. The first formula calculates a value based on the patient's age (in years) and weight (in kilograms), while the second formula calculates a value based on the patient's serum creatinine level (in milligrams per deciliter) and a constant of 72 (with a correction factor of 0.85 for female patients).*

Gabapentin is a medication available in the form of 600mg tablets. These tablets were manufactured by Glenmark Pharmaceuticals and packaged by Vangard Labs, located in Glasgow, KY 42141. The tablets have LOT numbers of 8233 and 1078233 with an expiration date of EXP. The medication is intended only for institutional use and must be stored at a temperature of 20°C-25°C. The tablets are indicated for the treatment of seizures and neuropathic pain.*

This appears to be a graph or table displaying mean pain scores for a study with a 3-week dose titration period followed by a 4-week fixed-dose period. The table includes placebo and two different dosages of gabapentin (1800mg/day and 2400mg/day). The baseline and weeks are also included in the table.*

The text describes a chart or figure labeled "Proportion of Responders" that shows the percentage of patients who experienced a 50% reduction in pain score at the end of controlled PHN (postherpetic neuralgia) studies. The chart shows percentages ranging from 0% to 100%, in increments of 10%. The chart also includes labels indicating the p-values of the studies: p<0.01 and p<0.001. The chart includes information for two studies, labeled "Study 1" and "Study 2," with respective treatment groups of PBO, GBP 3600, PBO, GBP 1800, and GBP 2400.*

This text appears to be a label of Gabapentin Tabs USP 600mg medication manufactured by Glenmark. It contains information about the product such as its name, dosage, and batch number. The label also provides details about the manufacturer, distributor, and usage instructions. It is not possible to determine the language from this text.*